Corey Mangold - Orchid Ventures CEO CoFounder

All Insiders . USA . 
Stock . Orchid Ventures . Stakeholders . Insider . Corey Mangold

Insider

Corey Mangold is CEO CoFounder of Orchid Ventures
Phone949 514 8012
Webhttps://www.orchidessentials.com

Orchid Ventures Management Efficiency

The company has return on total asset (ROA) of (1.8397) % which means that it has lost $1.8397 on every $100 spent on assets. This is way below average. Orchid Ventures' management efficiency ratios could be used to measure how well Orchid Ventures manages its routine affairs as well as how well it operates its assets and liabilities.
Orchid Ventures has accumulated 194.87 K in total debt with debt to equity ratio (D/E) of 1.7, which is about average as compared to similar companies. Orchid Ventures has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Orchid Ventures until it has trouble settling it off, either with new capital or with free cash flow. So, Orchid Ventures' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Orchid Ventures sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Orchid to invest in growth at high rates of return. When we think about Orchid Ventures' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Alex DasallaCollegium Pharmaceutical
N/A
Rami LevyINC Research Holdings
59
Raymond CoffmancbdMD Inc
62
John WestoncbdMD Inc
N/A
Kevin MacDermottcbdMD Inc
62
Scott SudduthCollegium Pharmaceutical
N/A
Jeff HolmBiofrontera
N/A
Muthusamy RPhANI Pharmaceuticals
56
Amos CohenINC Research Holdings
45
Marlo ManningCollegium Pharmaceutical
N/A
BCom BAccAkanda Corp
44
OriMoni MimonINC Research Holdings
36
Hermann LubbertBiofrontera
68
Matthew CoapmancbdMD Inc
48
CCFP DipSportMedEvolus Inc
60
Mark BaldygaBiofrontera
N/A
Elizabeth JDANI Pharmaceuticals
N/A
Eugene IIIBiofrontera
39
Tejinder VirkAkanda Corp
42
BComm BComAkanda Corp
68
Thomas FlowAkanda Corp
46
Orchid Ventures, Inc. engages in the design, development, manufacturing, branding, and distribution of cannabis vape products in North America. Orchid Ventures, Inc. is headquartered in Ladera Ranch, California. Orchid Ventures operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. Orchid Ventures [ORVRF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Return On Asset-1.84

Orchid Ventures Leadership Team

Elected by the shareholders, the Orchid Ventures' board of directors comprises two types of representatives: Orchid Ventures inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orchid. The board's role is to monitor Orchid Ventures' management team and ensure that shareholders' interests are well served. Orchid Ventures' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orchid Ventures' outside directors are responsible for providing unbiased perspectives on the board's policies.
Corey Mangold, CEO CoFounder
Luke Hemphill, Co Sec
Eric Vaughan, Chief Officer
Jennifer Clifton, G Counsel

Orchid Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Orchid Ventures a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset-1.84
Profit Margin(2.38) %
Operating Margin(2.58) %
Current Valuation942.36 K
Shares Outstanding52.44 M
Shares Owned By Insiders8.34 %
Price To Book8.89 X
Price To Sales0.72 X
Revenue3.72 M
Gross Profit1.2 M

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors

Other Information on Investing in Orchid Pink Sheet

Orchid Ventures financial ratios help investors to determine whether Orchid Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Orchid with respect to the benefits of owning Orchid Ventures security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY